Zobrazeno 1 - 10
of 1 467
pro vyhledávání: ''
Autor:
Otis W. Brawley, Jeromie Ballreich, Lin Wang, Hwanhee Hong, Channing J. Paller, G. Caleb Alexander
Publikováno v:
Value Health
Objectives To assess the cost-effectiveness of systemic treatments for metastatic castration-sensitive prostate cancer from the US healthcare sector perspective with a lifetime horizon. Methods We built a partitioned survival model based on a network
Publikováno v:
Value Health
Adjuvant chemotherapy is not recommended for patients with average-risk stage II (T3N0) colon cancer. Nevertheless, a subgroup of these patients who are CDX2-negative might benefit from adjuvant chemotherapy. We evaluated the cost-effectiveness of te
Publikováno v:
Value in Health. 24:1746-1753
Objectives Real option value (ROV) is created when a drug enables a patient to live long enough to benefit from a future innovation. Few studies have quantified ROV in the real world. We aimed to estimate the ex post ROV for ipilimumab in metastatic
Publikováno v:
Value in Health. 23:1292-1299
Objectives Overall survival in chronic myeloid leukemia (CML) in chronic phase is not significantly different by treatment with first-line tyrosine kinase inhibitors (TKIs), but emerging evidence reveals differences in costs and safety profiles. We e
Autor:
Edith A. Perez, Hans-Peter Goertz, Joseph B. Babigumira, Louis P. Garrison, Solomon J. Lubinga, C. Tournier
Publikováno v:
Value in Health. 22:408-415
Objective The APHINITY trial assessed the effectiveness and the safety of adding pertuzumab to trastuzumab and chemotherapy (THP) compared to trastuzumab and chemotherapy (TH) in the adjuvant management of human epidermal growth factor 2-positive (HE
Publikováno v:
Value in Health, 22, 322-331. Elsevier Ltd.
© 2019 ISPOR–The Professional Society for Health Economics and Outcomes Research Background: Risk-sharing arrangements (RSAs) can be used to mitigate uncertainty about the value of a drug by sharing the financial risk between payer and pharmaceuti
Autor:
J. Woyach, Jeffrey P. Sharman, S. Coutre, Priti Patel, Talha Munir, Wojciech Jurczak, V. Banerji, J.C. Byrd, U. Emeribe, M.H. Wang, P. Walker, William G. Wierda, E. Flood, P. Ghia, G. Salles
Publikováno v:
Value in Health. 24:S3-S4
Autor:
G.M. Lanchoti Fiori, T. Teixeira Chadid, B. Mendes da Silva, I. Genov, C. Regis, B. Villas Boas
Publikováno v:
Value in Health. 24:S31-S32
Publikováno v:
Value in Health. 24:S19-S20
Autor:
Daniel M. Geynisman, Toni K. Choueiri, C. Gu, S. Huo, B. Stwalley, Ella X Du, Keith A. Betts, M. Burotto, S. Sendhil, B. McGregor, Camillo Porta, Cristina Suarez, Maria T Bourlon
Publikováno v:
Value in Health. 24:S28-S29